Evidence map›Paper›PMID 15897890›Full record

ArticleOncogene2005

Silencing of the Tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-beta.

Andrea E Varga, Nina V Stourman, Qiao Zheng, Alfiya F Safina, Lei Quan, Xiurong Li, Khalid Sossey-Alaoui, Andrei V Bakin

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Inhibitors of DNA methylation support TGF-β1-inducedJournal of periodontal & implant science · 2017
    Article
  7. Article
  8. Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Andrea E VargaDepartment of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Nina V Stourman
Qiao Zheng
Alfiya F Safina
Lei Quan
Xiurong Li
Khalid Sossey-Alaoui
Andrei V Bakin
Cancer Genetics (United States) · USRoswell Park Comprehensive Cancer Center · US

Funding

Mechanisms of TGFbeta-mediated fibroblastic transitionR01CA095263 · NCI · VANDERBILT UNIVERSITY · PI BAKIN, ANDREI · 2002 to 2006
$1.6M
NCI NIH HHS R01 CA95263
6 · The paper itself

Abstract

Loss of actin stress fibers has been associated with cell transformation and metastasis. TGF-beta induction of stress fibers in epithelial cells requires high molecular weight tropomyosins encoded by TPM1 and TPM2 genes. Here, we investigated the mechanism underlying the failure of TGF-beta to induce stress fibers and inhibit cell migration in metastatic cells. RT-PCR analysis in carcinoma cell lines revealed a significant reduction in TPM1 transcripts in metastatic MDA-MB-231, MDA-MB-435 and SW620 cell lines. Treatment of these cells with demethylating agent 5-aza-2'-deoxycytidine (5-aza-dC) increased mRNA levels of TPM1 with no effect on TPM2. Importantly, 5-aza-dC treatment of MDA-MB-231 cells restored TGF-beta induction of TPM1 and formation of stress fibers. Forced expression of TPM1 by using Tet-Off system increased stress fibers in MDA-MB-231 cells and reduced cell migration. A potential CpG island spanning the TPM1 proximal promoter, exon 1, and the beginning of intron 1 was identified. Bisulfite sequencing showed significant cytosine methylation in metastatic cell lines that correlated with a reduced expression of TPM1. Together these results suggest that epigenetic suppression of TPM1 may alter TGF-beta tumor suppressor function and contribute to metastatic properties of tumor cells.

Indexed as

DNA MethylationGene SilencingGenes, Tumor SuppressorAzacitidineBase SequenceBreast NeoplasmsCell Line, TumorDecitabineExonsFemaleGene Expression Regulation, NeoplasticHumansIntronsMolecular Sequence DataNeoplasm MetastasisPromoter Regions, GeneticAzacitidineDecitabineRNA, MessengerTPM1 protein, humanTransforming Growth Factor betaTropomyosin

Identifiers

PMID15897890
OpenAlexW1984327683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.